Efficacy of naltrexone on acetylcholine-induced alloknesis in atopic eczema

Experimental Dermatology

Volumn 11, Issue 5, 2002, Pages 448-455

  Heyer, Gisela ^a   Groene, D ^a   Martus, P ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Acetylcholine; Atopic eczema; Naltrexone (Nemexin ); Pruritus

Indexed keywords

ACETYLCHOLINE; CORTICOSTEROID DERIVATIVE; NALTREXONE; NEMEXIN; OPIATE; OPIATE RECEPTOR; SODIUM CHLORIDE; NARCOTIC ANTAGONIST;

ADRENERGIC SYSTEM; ADULT; AREA UNDER THE CURVE; ARTICLE; ATOPIC DERMATITIS; BLOOD VESSEL REACTIVITY; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; ERYTHEMA; FEMALE; FOREARM; HUMAN; INJECTION SITE; LASER DOPPLER FLOWMETRY; MALE; NOCICEPTION; PATHOPHYSIOLOGY; PRURITUS; SKIN SENSATION; SKIN STIMULATION; URTICARIA; VISUAL ANALOG SCALE; BLOOD FLOW VELOCITY; DRUG EFFECT; MIDDLE AGED; NOCICEPTIVE RECEPTOR; PHYSIOLOGY; SKIN; STIMULATION; VASCULARIZATION;

ACETYLCHOLINE; ADULT; BLOOD FLOW VELOCITY; DERMATITIS, ATOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; NOCICEPTORS; PHYSICAL STIMULATION; PRURITUS; SKIN;

EID: 0036780596     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2002.110508.x     Document Type: Article

References (45)

1. Heyer G, Hornstein O P. Recent studies of cutaneous nocieption in atopic and non-atopic subjects. J Dermatol 1999: 2: 77-86.
2. Vogelgsang M, Heyer G, Hornstein O P. Acetylcholine induces different cutaneous sensations in atopic and non-atopic subjects. Acta Derm Venereol 1995: 75: 434-436.
3. Wahlgren C F. Itch and atopic dermatitis: Clinical and experimental studies. Acta Derm Venereol 1991: 65: 1-53.
4. Greaves M W. Pathophysiology and clinical aspects of pruritus. In: Fitzpatrick, T. B, Eisen, A Z, Wolff, K, Freedberg, I M, Austen, K, eds. Dermatology in General Medicine, 4th edn. New York: McGraw-Hill, 1994: 413-421.
5. Rukwied R, Lischetzki G, McGlone F, Heyer G, Schmelz M. Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: A dermal microdialysis study. Br J Dermatol 2000: 142: 1114-1120.
6. Groene D, Martus P, Heyer G. Doxepin affects acetylcholine induced cutaneous reactions in atopic eczema. Exp Dermatol 2001: 10: 110-117.
7. 1 antagonist effects on histamine induced pruritus and alloknesis. Pain 1997: 73: 239-243.
8. Uehara M. Reduced histamine reaction in atopic dermatitis. Arch Dermatol 1982: 118: 244-245.
9. Rukwied R, Heyer G. Cutaneous reactions and sensations after intracutaneous injection of vasoactive intestinal polypeptide and acetylcholine in atopic eczema patients and healthy controls. Arch Dermatol Res 1998: 290: 198-120.
10. Klein P A, Clark R A. An evidence based review of the efficacies of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999: 135: 1522-1525.
11. Weihe E, Reinecke M. Peptidergic (Neurotensin, VIP, SP) nerve fibres in the skin. Immunohistochemical evidence of an involvement of neuropeptides in nociception, pruritus and inflammation. Br J Dermatol 1983: 109: 14-17.
12. Giannetti A, Fantini F, Cimitan A, Pincelli C. Vasoactive intestinal polypeptide and substance P in the pathogenesis of atopic dermatitis. Acta Derm Venerol Suppl. (Stockh) 1992: 176: 90-92.
13. Misery L. Skin, immunity and the nervous system. Br J Dermatol 1997: 137: 843-865.
14. Heyer G, Groene D. Acetylcholine as pruritugenic mediator. 7th Congress of the European Academy of Dermatology Venereology, 1998: 11: 59.
15. Rukwied R, Heyer G. Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients. Exp Dermatol 1999: 8: 39-45.
16. Nemexin Fachinformation. Du Pont 1999. Alendorf: Bundesverband der Pharmazeutischen Industrie e. V., 1999.
17. Porter S J, Somogyi A A, White J M. Kinetics and inhibition of the formation of 6 beta-naltrexol from naltrexone in human. Br J Clin Pharmacol 2000: 50: 465-471.
18. Pauli-Magnus C, Mikus G, Alscher D M et al. Naltrexone does not relieve uraemic pruritus: Results of a randomized, double blind, placebo-controlled crossover study. J Am Soc Nephrol 2000: 11: 514-519.
19. Wolfhagen F H, Sternieri E, Hop W C, Vitale G, Bertolotti M, Van Buuren H R. Oral naltexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study. Gastroenterology 1997: 113: 1264-1269.
20. Bergasa N V, Talbot T L, Alling D W. Controlled antipruritic trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992: 102: 544-549.
21. Peer G, Kivity S, Agami O et al. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 1996: 348: 1552-1554.
22. Metze D, Reimann S, Luger T A. Effective treatment of pruritus with naltrexone, an orally active opiate antagonist. Ann N Y Acad Sci 1999: 20: 430-432.
23. Metze D, Reimann S, Beissert S, Luger T. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol 1999: 41: 533-539.
24. Feuerstein T J, Albrecht C, Wessler I, Zentner J, Jackisch R. Detal 1 opioid receptor-mediated control of acetylcholine release in human neocortex slices. Int J Dev Neurosci 1998: 16: 795-802.
25. Summerfield J A. Naloxone modulates the perception of itch in man. Br J Clin Pharmacol 1980: 10: 180-183.
26. Fjellner B, Hägermark Ö. Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK 33-824, beta-endorphin and morphine. Arch Dermatol Res 1982: 274: 29-37.
27. Nissen J B, Kragballe K. Enkephalins modulate differentiation of normal human keratinocytes in vitro. Exp Dermatol 1997: 6: 222-229.
28. Grando S A, Kist D A, Qi M, Dahl M V. Human keratinocytes synthesize, secrete and degrade acetylcholine. J Invest Dermatol 1993: 101: 32-36.
29. Scott A. Acetylcholine in normal and diseased skin. Br J Dermatol 1962: 74: 317-322.
30. Schmelz M, Schmidt R, Bickel A, Handwerker H O, Torebjörk H E. Specific C-receptors for itch in human skin. J Neurosci 1997: 17: 8003-8008.
31. Bigliardi-Qi M, Mei Bigliardi P L, Eberle A, Rufli T. Beta endorphin stimulates cytokeratin 16 expression and down-regulates mu-opiate receptor expression in human epidermis. J Invest Dermatol 2000: 114: 527-532.
32. Diepgen T L, Fartasch M, Horstein O P. Evaluation and relevance of atopic basic and minor features in patients with atopic dermatitis and in general population. Acta Derm Venereol 1989: 144: 50-54.
33. Hanifin J M, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Suppl) (Stockh) 1980: 92: 44-47.
34. Zung W W K. A self-rating depression scale. Arch General Psychiat 1965: 12: 63-70.
35. Gupta M A, Gupta A K. Depression modulates pruritus perception. A study of pruritus in psoriasis, atopic dermatitis and chronic idiopathic urticaria. Ann N Y Acad Sci 1999: 885: 394-395.
36. Chabane N, Leboyer M, Mouren-Simeoni M C. Opiate antagonists in children and adolescents. Eur Child Adolesc Psychiatry 2000: 9: 144-150.
37. Inagaki N, Nakamura N, Nagao M et al. Inhibition of passive cutaneous anaphylaxis-associated scratching behaviour by mu-opioid receptor antagonists in ICR mice. Int Arch Allergy Immunol 2000: 123: 365-368.
38. Tennyson H, Levine N. Neutropic and psychotropic drugs in dermatology. Dermatol Clin 2001: 19: 179-197.
39. Faulstich M E, Williamson D A, Duchmann E G, Conerly S L, Brantley P J. Psychophysiological analysis of atopic dermatitis. J Psychosom Res 1985: 29: 415-417.
40. Handwerker H O, Magerl W, Klemm F et al. Fine afferent nerve fibers and pain. In: Schmidt, R F, Schaible, H G, Vahle-Hinz, C, eds. Quantitative Evaluation of Itch Sensation. Weinheim: VHC-Verlagsgesellschaft, 1987: 461-473.
41. Ryan T J. Vascular reactivity in atopic eczema. In: Ruzicka, T, Ring, J, Przybilla, B, eds. Handbook of Atopic Eczema. New York: Springer Verlag, 1991: 263-277.
42. Brain S D, Williams W J, Tippins J R, Morris H R, McIntyre I. Calcitonin gene related peptide is a potent vasodilator. Nature 1985: 313: 54-56.
43. Schmelz M. A neural pathway for itch. Nat Neurosci 2001: 4: 9-10.
44. Wahlgren C F. Itch and atopic dermatitis: An overview. J Dermatol 1999: 26: 770-779.
45. Schmelz M, Michael K, Weidner C, Schmidt R, Torebjörk H E, Handwerker H O. Which nerve fibers mediate the axon reflex flare in human skin? Neuroreport 2000: 11: 645-648.